These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 9815550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA.
    Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664
    [Abstract] [Full Text] [Related]

  • 3. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I, Chen D, Lotan R, Yang P, Newman RA, Fischer SM, Lippman SM.
    Cancer Res; 2000 Dec 15; 60(24):6846-50. PubMed ID: 11156377
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF, Shewmake K, Beer DG, Cryer B, Spechler SJ.
    Cancer Res; 2000 Oct 15; 60(20):5767-72. PubMed ID: 11059772
    [Abstract] [Full Text] [Related]

  • 5. Expression of cyclooxygenase-2 (COX-2) in hepatocellular carcinoma and growth inhibition of hepatoma cell lines by a COX-2 inhibitor, NS-398.
    Bae SH, Jung ES, Park YM, Kim BS, Kim BK, Kim DG, Ryu WS.
    Clin Cancer Res; 2001 May 15; 7(5):1410-8. PubMed ID: 11350912
    [Abstract] [Full Text] [Related]

  • 6. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
    Rodríguez-Burford C, Barnes MN, Oelschlager DK, Myers RB, Talley LI, Partridge EE, Grizzle WE.
    Clin Cancer Res; 2002 Jan 15; 8(1):202-9. PubMed ID: 11801560
    [Abstract] [Full Text] [Related]

  • 7. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN.
    Clin Cancer Res; 2001 Oct 15; 7(10):2998-3005. PubMed ID: 11595687
    [Abstract] [Full Text] [Related]

  • 8. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC, Wang S, Zhang H, Ye YJ, Liang B, Cui ZR.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):583-6. PubMed ID: 15144595
    [Abstract] [Full Text] [Related]

  • 9. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G, Schulze-Osthoff K, Jänicke RU.
    Oncogene; 2003 Sep 11; 22(39):8021-30. PubMed ID: 12970750
    [Abstract] [Full Text] [Related]

  • 10. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
    Grösch S, Tegeder I, Niederberger E, Bräutigam L, Geisslinger G.
    FASEB J; 2001 Dec 11; 15(14):2742-4. PubMed ID: 11606477
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
    Uefuji K, Ichikura T, Shinomiya N, Mochizuki H.
    Anticancer Res; 2000 Dec 11; 20(6B):4279-84. PubMed ID: 11205258
    [Abstract] [Full Text] [Related]

  • 13. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS, Davis TW, Ornberg RL, Masferrer JL.
    Cancer Res; 2002 Nov 15; 62(22):6706-11. PubMed ID: 12438270
    [Abstract] [Full Text] [Related]

  • 14. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA, Longo WE, Panesar N, Mazuski JE, Kaminski DL.
    J Surg Res; 1999 Jan 15; 81(1):101-7. PubMed ID: 9889067
    [Abstract] [Full Text] [Related]

  • 15. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs.
    Lee DW, Sung MW, Park SW, Seong WJ, Roh JL, Park B, Heo DS, Kim KH.
    Anticancer Res; 2002 Jan 15; 22(4):2089-96. PubMed ID: 12174888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
    Elder DJ, Halton DE, Crew TE, Paraskeva C.
    Int J Cancer; 2000 May 15; 86(4):553-60. PubMed ID: 10797271
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE, Elder DJ, Paraskeva C.
    Carcinogenesis; 2000 Jan 15; 21(1):69-77. PubMed ID: 10607736
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.